Surgery Partners, Inc.
SGRY
$24.05
-$0.11-0.46%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 770.40M | 762.10M | 717.40M | 735.40M | 674.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 770.40M | 762.10M | 717.40M | 735.40M | 674.10M |
| Cost of Revenue | 592.90M | 582.90M | 562.10M | 541.80M | 508.30M |
| Gross Profit | 177.50M | 179.20M | 155.30M | 193.60M | 165.80M |
| SG&A Expenses | 29.20M | 40.30M | 33.20M | 20.90M | 36.80M |
| Depreciation & Amortization | 50.20M | 34.80M | 33.70M | 31.10M | 28.90M |
| Other Operating Expenses | -2.20M | -6.50M | -2.00M | -4.30M | -1.20M |
| Total Operating Expenses | 670.10M | 651.50M | 627.00M | 589.50M | 572.80M |
| Operating Income | 100.30M | 110.60M | 90.40M | 145.90M | 101.30M |
| Income Before Tax | 10.90M | 33.30M | 28.70M | 52.70M | 32.80M |
| Income Tax Expenses | 4.50M | 4.90M | 4.40M | 6.00M | 3.10M |
| Earnings from Continuing Operations | 6.40M | 28.40M | 24.30M | 46.70M | 29.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -38.10M | -43.90M | -36.70M | -47.70M | -34.60M |
| Net Income | -31.70M | -15.50M | -12.40M | -1.00M | -4.90M |
| EBIT | 100.30M | 110.60M | 90.40M | 145.90M | 101.30M |
| EBITDA | 150.50M | 145.40M | 124.10M | 177.00M | 130.20M |
| EPS Basic | -0.25 | -0.12 | -0.10 | -0.01 | -0.04 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.06 | 0.13 | 0.00 |
| EPS Diluted | -0.25 | -0.12 | -0.10 | -0.01 | -0.04 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.06 | 0.13 | 0.00 |
| Average Basic Shares Outstanding | 126.17M | 126.13M | 125.97M | 125.77M | 125.75M |
| Average Diluted Shares Outstanding | 126.17M | 126.13M | 125.97M | 125.77M | 125.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
